OTC Markets OTCPK - Delayed Quote USD
Gritstone bio, Inc. (GRTSQ)
At close: November 7 at 3:00 PM EST
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.17 | -0.16 | -0.84 | -0.86 |
| Low Estimate | -0.17 | -0.16 | -0.84 | -0.86 |
| High Estimate | -0.17 | -0.16 | -0.84 | -0.86 |
| Year Ago EPS | -0.33 | -0.26 | -1.2 | -0.84 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | 2.7M | -- |
| Low Estimate | -- | -- | 2.7M | -- |
| High Estimate | -- | -- | 2.7M | -- |
| Year Ago Sales | -- | 10.38M | 16.34M | 2.7M |
| Sales Growth (year/est) | -- | -- | -83.50% | -- |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.33 | -0.33 | -0.32 | -0.28 |
| EPS Actual | -0.33 | -0.26 | -0.34 | -0.16 |
| Difference | 0 | 0.07 | -0.02 | 0.12 |
| Surprise % | 0.00% | 21.20% | -6.30% | 42.90% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.17 | -0.16 | -0.84 | -0.86 |
| 7 Days Ago | -0.17 | -0.16 | -0.84 | -0.86 |
| 30 Days Ago | -0.17 | -0.17 | -0.84 | -0.8 |
| 60 Days Ago | -0.19 | -0.19 | -0.9 | -0.89 |
| 90 Days Ago | -0.23 | -0.22 | -1.06 | -0.97 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | GRTSQ | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 48.50% | -- | -- | 5.80% |
| Next Qtr. | 38.50% | -- | -- | 12.10% |
| Current Year | 30.00% | -- | -- | 2.10% |
| Next Year | -2.40% | -- | -- | 12.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.05% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Downgrade | Jones Trading: Buy to Hold | 10/2/2024 |
| Downgrade | B. Riley Securities: Buy to Neutral | 10/2/2024 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 10/1/2024 |
| Downgrade | JMP Securities: Market Outperform to Market Perform | 10/1/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/15/2024 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 8/5/2024 |
Related Tickers
BRNS Barinthus Biotherapeutics plc
1.4715
-1.24%
LSTA Lisata Therapeutics, Inc.
2.9100
+1.39%
CUE Cue Biopharma, Inc.
1.7800
+7.88%
VINC Vincerx Pharma, Inc.
0.3222
-1.47%
SLXN Silexion Therapeutics Corp
0.2772
+8.32%
STTK Shattuck Labs, Inc.
1.2400
+0.81%
BCTX BriaCell Therapeutics Corp.
0.7088
+0.54%
EQ Equillium, Inc.
0.7655
+1.88%
GTBP GT Biopharma, Inc.
3.1000
+6.90%
REPL Replimune Group, Inc.
12.21
-3.86%